[go: up one dir, main page]

MX2009012358A - Agentes de formacion de imagenes opticas. - Google Patents

Agentes de formacion de imagenes opticas.

Info

Publication number
MX2009012358A
MX2009012358A MX2009012358A MX2009012358A MX2009012358A MX 2009012358 A MX2009012358 A MX 2009012358A MX 2009012358 A MX2009012358 A MX 2009012358A MX 2009012358 A MX2009012358 A MX 2009012358A MX 2009012358 A MX2009012358 A MX 2009012358A
Authority
MX
Mexico
Prior art keywords
optical imaging
imaging agents
imaging
vivo
kits
Prior art date
Application number
MX2009012358A
Other languages
English (en)
Inventor
Alan Cutherbertson
Edvin Wilhelm Johannesen
Michael Edward Cooper
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0709441A external-priority patent/GB0709441D0/en
Priority claimed from GB0715682A external-priority patent/GB0715682D0/en
Priority claimed from GB0716175A external-priority patent/GB0716175D0/en
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2009012358A publication Critical patent/MX2009012358A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/083—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines five >CH- groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a agentes de formación de imágenes adecuados para la formación de imágenes ópticas in vivo, los cuales comprenden conjugados de tintes de cianina de pentametina que tienen un enlace no específico reducido, por ejemplo, a proteínas de plasma. Esto se logra mediante el control de la naturaleza y ubicación de los sustituyentes de ácido sulfónico, en particular, de los grupos sulfoalquilo. También se describen composiciones y equipos farmacéuticos, así como también métodos de formación de imágenes in vivo.
MX2009012358A 2007-05-16 2008-05-16 Agentes de formacion de imagenes opticas. MX2009012358A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0709441A GB0709441D0 (en) 2007-05-16 2007-05-16 Peptide imaging agents
GB0715682A GB0715682D0 (en) 2007-08-13 2007-08-13 Peptide imaging agents
GB0716175A GB0716175D0 (en) 2007-08-20 2007-08-20 Optical imaging agents
PCT/GB2008/001693 WO2008139206A2 (en) 2007-05-16 2008-05-16 Optical imaging agents

Publications (1)

Publication Number Publication Date
MX2009012358A true MX2009012358A (es) 2010-02-17

Family

ID=39870387

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012358A MX2009012358A (es) 2007-05-16 2008-05-16 Agentes de formacion de imagenes opticas.

Country Status (12)

Country Link
US (1) US20100303727A1 (es)
EP (1) EP2148702A2 (es)
JP (1) JP2010527922A (es)
KR (1) KR20100017102A (es)
CN (1) CN101743022A (es)
AU (1) AU2008249820A1 (es)
BR (1) BRPI0811588A2 (es)
CA (1) CA2686089A1 (es)
IL (1) IL201794A0 (es)
MX (1) MX2009012358A (es)
NZ (1) NZ581161A (es)
WO (1) WO2008139206A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291706A1 (en) * 2009-05-15 2010-11-18 Millipore Corporation Dye conjugates and methods of use
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
WO2012001063A1 (en) 2010-06-29 2012-01-05 Ge Healthcare As Dye compositions and dye syntheses
EP2734043A4 (en) * 2011-07-20 2015-07-29 Univ Georgia State Res Found CELL RECOGNITION CONJUGATES AND METHODS FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE BY MEANS OF MALDI-MS IMAGING
WO2014035712A1 (en) * 2012-08-28 2014-03-06 Pierce Biotechnology, Inc. Benzopyrylium compounds
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
CN107206108B (zh) * 2014-12-19 2021-08-31 伯拉考成像股份公司 术中成像
EP3247802B1 (en) * 2015-01-22 2024-08-28 The Board of Trustees of the Leland Stanford Junior University Protease-activated contrast agents for in vivo imaging
WO2016127150A1 (en) * 2015-02-08 2016-08-11 Nanohybrids Methods of detecting biological activity, cellular behavior and drug delivery using encapsulated polymethine aggregates
CN104804463B (zh) * 2015-03-10 2016-08-24 西安交通大学第一附属医院 用于靶向肿瘤组织的近红外荧光染色剂及制备方法和应用
CN107739528A (zh) * 2017-09-30 2018-02-27 武汉工程大学 一种五肽改性菁染料化合物及其制备方法和应用
US20240131199A1 (en) * 2020-12-17 2024-04-25 Bracco Imaging S.P.A. Ph responsive cyanine dyes and conjugates thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US6593148B1 (en) * 1994-03-01 2003-07-15 Li-Cor, Inc. Cyanine dye compounds and labeling methods
IT1276833B1 (it) * 1995-10-09 1997-11-03 Sorin Biomedica Cardio Spa Coloranti fluorescenti della famiglia della solfo benz e indocianina
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
US7175953B2 (en) * 1999-04-09 2007-02-13 Institute Fuer Diagnostik Forschung Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
DE10018199A1 (de) * 2000-04-12 2001-10-31 Few Chemicals Gmbh Fluoreszenzmarker
CA2484218A1 (en) * 2002-05-10 2004-05-13 Ratnaker B. Mujumdar Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
JP4607859B2 (ja) * 2003-02-19 2011-01-05 サイセル・テクノロジーズ，インコーポレイテッド 蛍光分析物と連動して作動するインビボ蛍光センサ、システム及び関連方法
JP4943156B2 (ja) * 2003-10-31 2012-05-30 ジーイー・ヘルスケア・ユーケイ・リミテッド シアニン色素標識用試薬
CN101272808B (zh) * 2005-01-06 2012-03-21 通用电气医疗集团股份有限公司 光学成像
WO2006078914A1 (en) * 2005-01-21 2006-07-27 Washington University In St. Louis Compounds having rd targeting motifs
GB2425315B (en) * 2005-04-22 2009-10-07 Ge Healthcare Uk Ltd Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents
DK1937676T3 (en) * 2005-09-02 2017-03-06 Visen Medical Inc Biocompatible fluorescent imaging compounds
DE102006029454A1 (de) * 2005-12-05 2007-06-06 Dyomics Gmbh Hydrophile Marker auf Basis von diasteromeren
DK1792949T3 (da) * 2005-12-05 2010-12-06 Dyomics Gmbh Hydrofil markør på basis af diastereoisomere cyaniner
JP2010513476A (ja) * 2006-12-20 2010-04-30 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
ATE551073T1 (de) * 2007-05-16 2012-04-15 Ge Healthcare As Markierte hgf-bindende peptide für bildgebung

Also Published As

Publication number Publication date
NZ581161A (en) 2012-06-29
WO2008139206A3 (en) 2009-04-16
JP2010527922A (ja) 2010-08-19
KR20100017102A (ko) 2010-02-16
IL201794A0 (en) 2010-06-16
WO2008139206A2 (en) 2008-11-20
EP2148702A2 (en) 2010-02-03
CN101743022A (zh) 2010-06-16
AU2008249820A1 (en) 2008-11-20
US20100303727A1 (en) 2010-12-02
BRPI0811588A2 (pt) 2014-10-21
CA2686089A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
MX2009012358A (es) Agentes de formacion de imagenes opticas.
WO2009016181A3 (en) Optical imaging agents
CY1122210T1 (el) Ανθρωπινα αντισωματα anti-sod1
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
MX2018005512A (es) Agentes de union de esclerostina.
MX2015013223A (es) Sintesis y composicion de grupos de enlace de aminoacidos conjugados con compuestos usados para la toma de imagenes dirigida de tumores.
CU23978B1 (es) Composiciones para anticuerpos que se dirigen a la proteína de complemento c5
MX2011006422A (es) Autoanticuerpos humanos anti-alfa-sinucleina.
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
WO2012027623A3 (en) Cyanine dyes
BRPI0608376A8 (pt) composição de ligação, método de uso de uma composição de ligação, e, kit de detecção
MX2010005022A (es) Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas.
MY174493A (en) Binding agents
BR112015014751A2 (pt) anticorpos anti-tau humanos
EP4218802A3 (en) Conjugates for targeted cell surface editing
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
MX2018008680A (es) Moleculas de union especifica a proteina de union a adn de respuesta transactiva de 43 kda (tdp-43).
MX378130B (es) Métodos y composiciones de nanopartículas sin priones.
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
WO2010058393A3 (en) Compositions and methods for the prognosis of colon cancer
WO2010122426A3 (en) Methods and compositions for visualization of fluorescent proteins
ATE539152T1 (de) Neue verfahren
EA201170702A1 (ru) Способ получения производных дезоксирибофуранозы
EA200701752A1 (ru) Способ получения усовершенствованных фармакокинетических соединений, включающих функциональные остатки или группы, и фармацевтические композиции, содержащие эти соединения

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal